24 September 2013 | News | By BioSpectrum Bureau
Biosafe's proprietary Sepax cell separation system and Coolmix cryo-preparation cooling and mixing device is gaining popularity in Brazil, Russia, India and China (BRIC)
Singapore: Biosafe, which is a Switzerland-based manufacturer of automated cell processing systems, partnered with Indian distributor, Span Healthcare, with the objective to expand its stem cell banking business in India.
In the domain of public stem cell banking, Jeevan Blood Bank and Research Center in Chennai is expanding its program and will process its full volume of stem cell samples with Biosafe's proprietary Sepax cell separation system and Coolmix cryo-preparation cooling and mixing device.
In the doamin of family stem cell banking, the renowned companies Cordlife India and Cryobanks International are likewise moving to automated processing exclusively by Sepax.
Mr Olivier Waridel, CEO, Biosafe Group, commented that, "These recent wins illustrate the potential of Biosafe's Sepax technology in Brazil, Russia, India and China (BRIC) economies. Biosafe demonstrates its ability to meet customer expectations through its vast portfolio of processing solutions and is committed to further support stem cell banking expansion in India together with Span Healthcare."